150 related articles for article (PubMed ID: 7301710)
1. Agonist potencies of tryptamine derivatives at pre- and postjunctional receptors in canine saphenous vein.
Müller-Schweinitzer E
Postgrad Med J; 1981; 57 Suppl 1():36-44. PubMed ID: 7301710
[TBL] [Abstract][Full Text] [Related]
2. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
Cohen ML; Schenck KW; Hemrick-Luecke SH
J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
Cohen ML; Schenck K
J Pharmacol Exp Ther; 1999 Sep; 290(3):935-9. PubMed ID: 10454462
[TBL] [Abstract][Full Text] [Related]
4. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
[TBL] [Abstract][Full Text] [Related]
5. Subtypes of muscarinic receptors on adrenergic nerves and vascular smooth muscle of the canine saphenous vein.
O'Rourke ST; Vanhoutte PM
J Pharmacol Exp Ther; 1987 Apr; 241(1):64-7. PubMed ID: 3572796
[TBL] [Abstract][Full Text] [Related]
6. The actions of 5-hydroxytryptamine receptor agonists and antagonists at pre- and postjunctional level on the canine saphenous vein.
Paiva MQ; Caramona MM; Osswald W
Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):616-22. PubMed ID: 2977424
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
Rimele TJ; Aarhus LL; Lorenz RR; Rooke TW; Vanhoutte PM
J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
Prins NH; Briejer MR; Schuurkes JA
Br J Pharmacol; 1997 Feb; 120(4):714-20. PubMed ID: 9051313
[TBL] [Abstract][Full Text] [Related]
10. Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins.
Curro FA; Greenberg S; Verbeuren TJ; Vanhoutte PM
J Pharmacol Exp Ther; 1978 Dec; 207(3):936-49. PubMed ID: 215746
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous measurement of [3H]noradrenaline release and neurogenic contraction under identical conditions, to determine the prejunctional inhibitory effects of SKF 99101H and BRL 56905 in dog saphenous vein.
Medhurst AD; Brown AM; Kaumann AJ; Parsons AA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):475-82. PubMed ID: 9109364
[TBL] [Abstract][Full Text] [Related]
12. Lack of pre- and postjunctional beta adrenoceptor-mediated effects in the canine saphenous vein at birth.
Guimarães S; Moura D; Paiva MQ; Vaz-da-Silva MJ
J Pharmacol Exp Ther; 1994 Feb; 268(2):990-5. PubMed ID: 8114015
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serotonin and tryptamine receptors in the rat stomach fundus.
Cohen ML; Wittenauer LA
J Pharmacol Exp Ther; 1985 Apr; 233(1):75-9. PubMed ID: 3981465
[TBL] [Abstract][Full Text] [Related]
14. Investigation into the contractile response of melatonin in the guinea-pig isolated proximal colon: the role of 5-HT4 and melatonin receptors.
Lucchelli A; Santagostino-Barbone MG; Tonini M
Br J Pharmacol; 1997 Aug; 121(8):1775-81. PubMed ID: 9283717
[TBL] [Abstract][Full Text] [Related]
15. Evidence that halothane inhibits norepinephrine release from sympathetic nerve endings in dog saphenous vein by stimulation of presynaptic inhibitory muscarinic receptors.
Rorie DK; Tyce GM; Mackenzie RA
Anesth Analg; 1984 Dec; 63(12):1059-64. PubMed ID: 6507906
[TBL] [Abstract][Full Text] [Related]
16. A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein.
Watts AD; Feniuk W; Humphrey PP
J Pharm Pharmacol; 1981 Aug; 33(8):515-20. PubMed ID: 6115926
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein.
Feniuk W; Humphrey PP; Watts AD
Br J Pharmacol; 1979 Oct; 67(2):247-54. PubMed ID: 497528
[TBL] [Abstract][Full Text] [Related]
18. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
19. Gallamine and pancuronium inhibit pre- and postjunctional muscarine receptors in canine saphenous veins.
Vercruysse P; Bossuyt P; Hanegreefs G; Verbeuren TJ; Vanhoutte PM
J Pharmacol Exp Ther; 1979 May; 209(2):225-30. PubMed ID: 438998
[TBL] [Abstract][Full Text] [Related]
20. Serotonin-induced contraction in canine coronary artery and saphenous vein: role of a 5-HT1D-like receptor.
Cushing DJ; Baez M; Kursar JD; Schenck K; Cohen ML
Life Sci; 1994; 54(22):1671-80. PubMed ID: 7909909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
